BENDHEIM JACK

PrivateCIK: 1241560
Location

TEANECK, NJ

BENDHEIM JACK (President and CEO) sold 47.4% of their position (110.84K shares) of PHIBRO ANIMAL HEALTH CORP on the open market

Open‑market sale worth $5.36M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 6 sales
InsiderBENDHEIM JACKCIK 1241560
IssuerPHIBRO ANIMAL HEALTH CORPCIK 1069899
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-110.84K
Net shares
Net seller
$5.36M
Total sold
6
Open market trades
0B · 6S
8
Total transactions
185K acquired · 295.84K disposed
Non-Derivative Transactions7

Class A Common Stock

Indirect
C · Conversion

Shares

+185K

Price / share

Trade value

% of position

379.1%
2/5/2026
48.80K233.80K

Class A Common Stock

Indirect
S · Sale

Shares

409.00

Price / share

$44.47

Trade value

$18.19K

% of position

0.2%
2/5/2026
233.80K233.39K

Class A Common Stock

Indirect
S · Sale

Shares

3.64K

Price / share

$45.42

Trade value

$165.34K

% of position

1.6%
2/5/2026
233.39K229.75K

Class A Common Stock

Indirect
S · Sale

Shares

3.17K

Price / share

$46.68

Trade value

$148.03K

% of position

1.4%
2/5/2026
229.75K226.58K

Class A Common Stock

Indirect
S · Sale

Shares

38.21K

Price / share

$47.91

Trade value

$1.83M

% of position

16.9%
2/5/2026
226.58K188.37K

Class A Common Stock

Indirect
S · Sale

Shares

46.27K

Price / share

$48.65

Trade value

$2.25M

% of position

24.6%
2/5/2026
188.37K142.10K

Class A Common Stock

Indirect
S · Sale

Shares

19.14K

Price / share

$49.57

Trade value

$948.71K

% of position

13.5%
2/5/2026
142.10K122.96K
Total

Net shares

+74.16K

Net value

-$5.36M

Derivative Transactions1

Class B Common Stock

Indirect
C · Conversion
Converts to

Class A Common Stock

185K shares

Shares

185K

Strike price

0

Held after

19.70M

Exercisable

2/5/2026
Non-Derivative Holdings (Post-Transaction)1

Class A Common Stock

Direct
Shares owned16.84K
Total
16.84K direct16.84K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
BENDHEIM JACK — Insider Transaction (Form 4) Filed Feb 9, 2026 | Finecho